Physician profile
Lori Dobbin
NPI 1740311646
$1,427.69
in general payments reported to CMS, 2019-2025
20 companies · $117 in 2025
The $117 reported for 2025 was less than what a typical Women'S Health (Nurse Practitioner) provider received nationally (typical 2025 total: $123).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $692 · 2022: $374 · 2023: $47.24 · 2024: $198 · 2025: $117.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $362.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $362.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $290.14 | 2021-2023 | |
| Exeltis, USA INC. | $157.47 | 2021-2022 | |
| Innovation Technologies INC | $131.75 | 2024 | Irrisept |
| Evofem Biosciences, INC. | $119.34 | 2021-2025 | Solosec, Phexx, Phexxi |
| Pfizer INC. | $104.79 | 2021-2022 | |
| Hologic Sales and Service, LLC | $81.03 | 2021-2023 | Novasure |
| Novo Nordisk INC | $70.44 | 2021-2025 | Wegovy |
| Avion Pharmaceuticals | $58.92 | 2021-2022 | |
| Astellas Pharma US INC | $49.79 | 2021-2025 | Veozah |
| Therapeuticsmd, INC. | $48.18 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $46.18 | 2024 | Myfembree |
| Agile Therapeutics, INC. | $43.41 | 2021-2022 | |
| Myovant Sciences INC. | $41.41 | 2021-2022 | |
| Biogen, INC. | $37.37 | 2024-2025 | Zurzuvae |
| Merck Sharp & Dohme LLC | $34.95 | 2021-2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scynexis, INC. | $28.18 | 2022 | |
| Organon LLC | $24.24 | 2022 | |
| Mayne Pharma Commercial LLC | $22.71 | 2022 | |
| Coopersurgical, INC. | $22.29 | 2025 | Paragard T 380a |
| Mission Pharmacal Company | $15.10 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lori Dobbin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.